Appistry, a provider of solutions that simplify the analysis of next-generation sequencing (NGS) data, has launched a Managed Services offering to help clinical laboratories accelerate the process with establishing and expanding NGS-based testing.
Clinical laboratories looking to establish or expand their NGS-based testing, face considerable challenges in the development and execution of NGS data analysis. Appistry’s Managed Services accelerates and enables the analysis of NGS data by managing the set-up and execution of a complete analytics environment from sequencer through data analysis and data management.
'In speaking with clinical lab directors, we found they all face similar challenges in launching or expanding their NGS-based testing capabilities,' said Appistry CEO Kevin Haar. 'The requirements of assembling a bioinformatics staff, configuring an IT infrastructure, and achieving regulatory compliance, result in a high overhead cost, long development process, and substantial delays in the lab’s ability to offer new or improved NGS-based tests.
'Appistry’s Managed Services reduce the resources, time and cost required by leveraging our deep expertise in bioinformatics, clinical informatics, high-performance computing, and data integration. What could typically take a laboratory months to build, Appistry can deliver in a few days or weeks enabling a lab to offer NGS-based testing quickly and cost-effectively.'